Literature DB >> 21653754

Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease.

Yogesh A Karpe1, Kavita S Lole1.   

Abstract

Hepatitis E virus (HEV) ORF1 protein (pORF1) contains methyltransferase (MetT), papain-like cysteine protease (PCP), RNA helicase (Hel) and RNA-dependent RNA polymerase (RdRp) domains. ORF1 sequence analysis showed two consensus LXGG cleavage sites at 664 and 1205. LXGG sequence is recognized by viral and cellular deubiquitinating enzymes. The protein encompassing the predicted MetT-PCP domains of HEV ORF1 was tested for deubiquitinating activity using fluorogenic substrates - ubiquitin-7-amino-4-methylcoumarin (AMC), IFN-stimulated gene 15 (ISG15)-AMC, Nedd8-AMC and SUMO-AMC. MetT-PCP cleaved all four substrates but processing of ISG15-AMC was more robust. There was no processing of the Hel and RdRp domains having the conserved (1205) LXGG site by the protein. MetT-PCP carried out deISGylation of the ISG15-conjugated cellular proteins, suggesting a possible role in combating cellular antiviral pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653754     DOI: 10.1099/vir.0.033738-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.

Authors:  P Shukla; H T Nguyen; K Faulk; K Mather; U Torian; R E Engle; S U Emerson
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

Review 2.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

3.  Hepatitis E virus replication requires an active ubiquitin-proteasome system.

Authors:  Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

Review 4.  Innate Immunity to Enteric Hepatitis Viruses.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

5.  A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.

Authors:  H T Nguyen; U Torian; K Faulk; K Mather; R E Engle; E Thompson; H L Bonkovsky; S U Emerson
Journal:  J Gen Virol       Date:  2011-11-23       Impact factor: 3.891

Review 6.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

7.  Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.

Authors:  Gayatri D Kanade; Kunal D Pingale; Yogesh A Karpe
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 8.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

Review 9.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Hepatitis E virus inhibits type I interferon induction by ORF1 products.

Authors:  Yuchen Nan; Ying Yu; Zexu Ma; Sunil K Khattar; Brenda Fredericksen; Yan-Jin Zhang
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.